MEI Pharma, Inc. Annual Operating Lease, Payments in USD from 2022 to 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
MEI Pharma, Inc. quarterly/annual Operating Lease, Payments history and growth rate from 2022 to 2024.
  • MEI Pharma, Inc. Operating Lease, Payments for the quarter ending September 30, 2024 was $0.000, a 100% decline year-over-year.
  • MEI Pharma, Inc. Operating Lease, Payments for the twelve months ending September 30, 2024 was $13M, a 470% increase year-over-year.
  • MEI Pharma, Inc. annual Operating Lease, Payments for 2024 was $13.6M, a 500% increase from 2023.
  • MEI Pharma, Inc. annual Operating Lease, Payments for 2023 was $2.27M, a 49.2% increase from 2022.
Operating Lease, Payments, Trailing 12 Months (USD)
Operating Lease, Payments, Annual (USD)
Operating Lease, Payments, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $13.6M +$11.3M +500% Jul 1, 2023 Jun 30, 2024 10-K 2024-09-19
2023 $2.27M +$748K +49.2% Jul 1, 2022 Jun 30, 2023 10-K 2024-09-19
2022 $1.52M Jul 1, 2021 Jun 30, 2022 10-K 2023-09-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.